By enhancing these signals, tirzepatide has been shown in clinical studies to support: Improved blood sugar regulation in adults with type 2 diabetes Weight management when paired with a balanced diet and regular physical activity Research indicates that tirzepatide may help increase feelings of fullness, reduce appetite, and support weight reduction
Semaglutide (brand names Ozempic and Wegovy) is a long-acting GLP-1 receptor agonist used for type 2 diabetes and weight management
What can help: Even small changes, like keeping a consistent bedtime or limiting screens at night, can make a difference
However, they have garnered never-before-seen levels of medical, media and business attention over the last few months, following the announcement of recent successful clinical trial results demonstrating the more widespread health benefits of certain GLP-1RAs
GLP-1 RAs are hypothesized to confer a cancer-risk benefit partly through anti-inflammatory mechanisms, in addition to their established effects on glycemic control and weight reduction
However, it is not suited for everyone